Arzneiwerk AG VIDA (LTS:0NKY) Other Current Liabilities: €0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0NKY Arzneiwerk AG VIDA LTS:0NKY
40 GF Score
Price €0.51
! 7 Warning Signs
View Full Analysis

What is Arzneiwerk AG VIDA Other Current Liabilities?

Arzneiwerk AG VIDA LTS:0NKY 40 Other Current Liabilities is €0.00 Mil as of Mar. 2026. GuruFocus rates LTS:0NKY with a GF Score™ of 40/100. The stock has 7 warning signs investors should review.

Arzneiwerk AG VIDA's other current liabilities for the quarter that ended in Mar. 2026 was €0.00 Mil.

Arzneiwerk AG VIDA's quarterly other current liabilities declined from Sep. 2025 (€0.00 Mil) to Dec. 2025 (€0.00 Mil) but then increased from Dec. 2025 (€0.00 Mil) to Mar. 2026 (€0.00 Mil).

Arzneiwerk AG VIDA's annual other current liabilities increased from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€0.01 Mil) but then declined from Dec. 2024 (€0.01 Mil) to Dec. 2025 (€0.00 Mil).

Arzneiwerk AG VIDA Other Current Liabilities Related Terms

Arzneiwerk AG VIDA Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Arzneiwerk AG VIDA's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arzneiwerk AG VIDA Other Current Liabilities Chart

Arzneiwerk AG VIDA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.12 0.00 0.01 0.00

Arzneiwerk AG VIDA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.00 0.00 0.00 0.00
LTS:0NKY
40GF Score
Arzneiwerk AG VIDA LTS:0NKY
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arzneiwerk AG VIDA Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €0.00 Mil mean?
Arzneiwerk AG VIDA (LTS:0NKY) has a Other Current Liabilities of €0.00 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Arzneiwerk AG VIDA.
Is Arzneiwerk AG VIDA's Other Current Liabilities too high?
Arzneiwerk AG VIDA's current Other Current Liabilities is €0.00 Mil. Overall, Arzneiwerk AG VIDA has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Arzneiwerk AG VIDA's Other Current Liabilities compare to MCK and COR?
Arzneiwerk AG VIDA's Other Current Liabilities of €0.00 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Distribution company?
A good Other Current Liabilities depends on the Medical Distribution industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Arzneiwerk AG VIDA. Arzneiwerk AG VIDA's current Other Current Liabilities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arzneiwerk AG VIDA stock overvalued right now?
Arzneiwerk AG VIDA (LTS:0NKY) has a current Other Current Liabilities of €0.00 Mil. The current Other Current Liabilities is €0.00 Mil. Arzneiwerk AG VIDA's overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Arzneiwerk AG VIDA (LTS:0NKY), the current Other Current Liabilities is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arzneiwerk AG VIDA Business Description

Other Exchanges TLIK:Germany
Address Ordensmeisterstrasse 15-16, Berlin, DEU, 12099
Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe.
40GF Score

Get the complete analysis for LTS:0NKY

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.51
Price